Intravitreal Bevacizumab and Cytokine Levels in Major and Macular Branch Retinal Vein Occlusion

Publisher： Karger

E-ISSN： 1423-0267|225|3|150-154

ISSN： 0030-3755

Source： Ophthalmologica, Vol.225, Iss.3, 2010-12, pp. : 150-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Bevacizumab Treatment for Macular Edema due to Branch Retinal Vein Occlusion in a Clinical Setting

By Siegel Ruth Axer   Dreznik Ayelet   Mimouni Karin   Bor Elite   Weinberger Dov   Bourla Dan Haim  

Current Eye Research, Vol. 37, Iss. 9, 2012-09 ,pp. : 823-829

Informa Healthcare

Access to resources Recommend Favorite

Prospective Pilot Study: Efficacy of Intravitreal Dexamethasone and Bevacizumab Injections in the Treatment of Macular Oedema Associated with Branch Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 230, Iss. 1, 2013-05 ,pp. : 43-49

Karger

Access to resources Recommend Favorite

Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular Oedema

By  

Ophthalmic Research, Vol. 56, Iss. 4, 2016-05 ,pp. : 207-214

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab and Aqueous Humor Factors/Cytokines in Major and Macular Branch Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 235, Iss. 4, 2016-03 ,pp. : 203-207

Karger

Access to resources Recommend Favorite

Early Intravitreal Bevacizumab for Non-Ischaemic Branch Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 223, Iss. 2, 2008-12 ,pp. : 124-127

Karger

Access to resources Recommend Favorite